Jonathan Allan - Dec 1, 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
GENERAL COUNSEL & CORP SEC
Signature
/s/ Jonathan Allan
Stock symbol
STOK
Transactions as of
Dec 1, 2024
Transactions value $
$0
Form type
4
Date filed
12/3/2024, 04:14 PM
Previous filing
May 22, 2024
Next filing
Dec 5, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Options Exercise $0 +33.9K +690.84% $0.00 38.8K Dec 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Restricted Stock Unit (RSU) Options Exercise $0 -33.9K -73.3% $0.00 12.4K Dec 1, 2024 Common Stock 33.9K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported total includes an aggregate 2,313 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d).
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F3 33,927 restricted stock units vest on December 1, 2024 and 12,357 will vest on December 1, 2025, subject to the reporting person's continued service to the Issuer on each such date.